ADAR1 Capital Management, LLC — Form 4 insider transactions
ADAR1 Capital Management, LLC — Full 13F portfolio →
Buys and sells reported on SEC Form 4 — filed within two business days of each trade when a filer's ownership in a stock crosses 10%. This is the fastest public window into what the manager is doing.
| Transaction date | Activity | Security | Shares | Price | Total | Filing |
|---|---|---|---|---|---|---|
| 2026-11-11 | Buy | NextCure, Inc. | 12,333 | $5.10 | $62,897 | SEC filing |
| 2026-11-06 | Buy | NextCure, Inc. | 3,662 | $5.10 | $18,676 | SEC filing |
| 2026-11-05 | Buy | InMed Pharmaceuticals Inc. | 2,640 | $13.10 | $34,572 | SEC filing |
| 2026-11-05 | Buy | NextCure, Inc. | 1,024 | $5.10 | $5,222 | SEC filing |
| 2026-10-27 | Buy | NextCure, Inc. | 3,553 | $5.10 | $18,104 | SEC filing |
| 2026-10-26 | Buy | NextCure, Inc. | 1,672 | $5.03 | $8,418 | SEC filing |
| 2026-10-23 | Buy | InMed Pharmaceuticals Inc. | 4 | $1.32 | $5 | SEC filing |
| 2026-10-23 | Buy | NextCure, Inc. | 5,626 | $4.83 | $27,170 | SEC filing |
| 2026-10-21 | Buy | TENAX THERAPEUTICS, INC. | 331,979 | $1.66 | $550,687 | SEC filing |
| 2026-10-20 | Buy | TENAX THERAPEUTICS, INC. | 254,342 | $1.60 | $405,726 | SEC filing |
| 2026-10-19 | Buy | TENAX THERAPEUTICS, INC. | 336,528 | $1.51 | $507,013 | SEC filing |
| 2026-10-19 | Buy | InMed Pharmaceuticals Inc. | 1,086 | $1.32 | $1,434 | SEC filing |
| 2026-10-16 | Buy | InMed Pharmaceuticals Inc. | 1 | $1.32 | $1 | SEC filing |
| 2026-10-15 | Buy | InMed Pharmaceuticals Inc. | 984 | $1.32 | $1,301 | SEC filing |
| 2026-10-14 | Buy | InMed Pharmaceuticals Inc. | 8,021 | $1.33 | $10,668 | SEC filing |
| 2026-10-13 | Buy | InMed Pharmaceuticals Inc. | 564 | $1.33 | $750 | SEC filing |
| 2026-10-08 | Buy | InMed Pharmaceuticals Inc. | 2,256 | $1.33 | $2,997 | SEC filing |
| 2026-10-07 | Buy | InMed Pharmaceuticals Inc. | 3,046 | $1.33 | $4,051 | SEC filing |
| 2026-10-06 | Buy | InMed Pharmaceuticals Inc. | 5,601 | $1.33 | $7,436 | SEC filing |
| 2026-10-05 | Buy | InMed Pharmaceuticals Inc. | 18,182 | $1.33 | $24,182 | SEC filing |
| 2026-10-02 | Buy | InMed Pharmaceuticals Inc. | 8,307 | $1.33 | $11,048 | SEC filing |
| 2026-10-01 | Buy | InMed Pharmaceuticals Inc. | 16,431 | $1.33 | $21,850 | SEC filing |
| 2026-09-16 | Buy | InMed Pharmaceuticals Inc. | 8,340 | $1.29 | $10,750 | SEC filing |
| 2026-09-15 | Buy | InMed Pharmaceuticals Inc. | 54,256 | $1.30 | $70,446 | SEC filing |
| 2026-09-14 | Buy | InMed Pharmaceuticals Inc. | 28,505 | $1.29 | $36,880 | SEC filing |
| 2026-09-03 | Buy | TENAX THERAPEUTICS, INC. | 900,000 | $1.78 | $1,604,160 | SEC filing |
| 2026-09-02 | Buy | TENAX THERAPEUTICS, INC. | 187,704 | $1.80 | $337,586 | SEC filing |
| 2026-09-01 | Buy | TENAX THERAPEUTICS, INC. | 179,058 | $1.80 | $321,570 | SEC filing |
| 2026-08-31 | Buy | TENAX THERAPEUTICS, INC. | 403,571 | $1.79 | $722,594 | SEC filing |
| 2026-08-24 | Buy | TENAX THERAPEUTICS, INC. | 107,374 | $1.75 | $188,355 | SEC filing |
| 2026-08-21 | Buy | TENAX THERAPEUTICS, INC. | 716,369 | $1.77 | $1,266,254 | SEC filing |
| 2026-08-20 | Buy | TENAX THERAPEUTICS, INC. | 202,124 | $1.78 | $359,538 | SEC filing |
| 2026-07-31 | Buy | NextCure, Inc. | 8,003 | $4.80 | $38,414 | SEC filing |
| 2026-07-31 | Buy | NextCure, Inc. | 25,000 | $4.98 | $124,540 | SEC filing |
| 2026-07-31 | Buy | NextCure, Inc. | 3,300 | $4.98 | $16,420 | SEC filing |
| 2026-07-30 | Buy | NextCure, Inc. | 77,850 | $4.96 | $385,793 | SEC filing |
| 2026-07-30 | Buy | NextCure, Inc. | 100,000 | $4.90 | $490,000 | SEC filing |
| 2026-07-30 | Buy | NextCure, Inc. | 25,000 | $4.81 | $120,338 | SEC filing |
| 2026-07-30 | Buy | NextCure, Inc. | 20,000 | $5.00 | $100,000 | SEC filing |
| 2026-07-30 | Buy | NextCure, Inc. | 50,000 | $4.97 | $248,615 | SEC filing |
| 2026-07-29 | Buy | NextCure, Inc. | 1,600 | $5.00 | $8,000 | SEC filing |
| 2026-07-29 | Buy | NextCure, Inc. | 1,810 | $5.00 | $9,050 | SEC filing |
| 2026-07-28 | Buy | NextCure, Inc. | 6,400 | $4.95 | $31,677 | SEC filing |
| 2026-07-27 | Buy | NextCure, Inc. | 7,798 | $5.00 | $38,985 | SEC filing |
| 2026-07-15 | Buy | InMed Pharmaceuticals Inc. | 1,000 | $1.55 | $1,555 | SEC filing |
| 2026-05-19 | Buy | InMed Pharmaceuticals Inc. | 200,000 | $1.50 | $299,800 | SEC filing |
| 2026-05-19 | Buy | InMed Pharmaceuticals Inc. | 200,000 | $1.56 | $312,080 | SEC filing |
| 2026-05-19 | Buy | InMed Pharmaceuticals Inc. | 68,551 | $1.60 | $109,668 | SEC filing |
| 2026-05-19 | Buy | Rallybio Corp | 200 | $13.80 | $2,760 | SEC filing |
| 2026-05-19 | Buy | Rallybio Corp | 10,000 | $13.98 | $139,822 | SEC filing |
| 2026-05-18 | Buy | Rallybio Corp | 6,009 | $13.98 | $83,981 | SEC filing |
| 2026-05-15 | Buy | Rallybio Corp | 200 | $13.95 | $2,790 | SEC filing |
| 2026-05-15 | Buy | Rallybio Corp | 100 | $13.80 | $1,380 | SEC filing |
| 2026-05-13 | Buy | Rallybio Corp | 75,178 | $14.00 | $1,052,492 | SEC filing |
| 2026-05-13 | Buy | Rallybio Corp | 4,081 | $13.80 | $56,315 | SEC filing |
| 2026-05-12 | Buy | Rallybio Corp | 800 | $13.83 | $11,063 | SEC filing |
| 2026-05-11 | Buy | Rallybio Corp | 19,900 | $14.00 | $278,600 | SEC filing |
| 2026-05-11 | Buy | Rallybio Corp | 25,000 | $14.00 | $350,000 | SEC filing |
| 2026-05-11 | Buy | Rallybio Corp | 5,100 | $14.00 | $71,392 | SEC filing |
| 2026-05-05 | Buy | Rallybio Corp | 35,101 | $14.00 | $491,260 | SEC filing |
| 2026-05-04 | Buy | Rallybio Corp | 116,904 | $13.97 | $1,633,207 | SEC filing |
| 2026-05-04 | Buy | Rallybio Corp | 3,900 | $13.90 | $54,201 | SEC filing |
How Form 4 differs from 13F
13F filings are quarterly snapshots, up to 45 days late. Form 4 is transaction-level and lands within two business days — but only covers stocks where the filer reports beneficial ownership above 10%. Pair the two: 13F for the whole portfolio, Form 4 for what the largest holders are doing right now.